PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Edetate→

Edetate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
64-02-8
Molecular formula
C10H12N2Na4O8
Molecular weight
380.17 g/mol
Drug class
EDTA chelating agentexact salt form must be confirmed (e.g. calcium disodium edetate versus disodium edetate)
Mechanism of action
Edetate forms stable coordination complexes with divalent and trivalent metal ions. The clinical behaviour and indication depend materially on the EDTA salt: calcium disodium edetate is used for lead chelation, whereas disodium edetate has a different calcium-binding profile and can cause severe hypocalcaemia.

Sources: US DailyMed — Edetate calcium disodium injection (lead chelation) · NCBI Bookshelf — EDTA pharmacology and salt-form distinctions · PubChem — Edetate disodium (distinct salt form) · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Edetate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Edetate Permitted Daily Exposure (PDE) report (the Edetate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Edetate Occupational Exposure Limit (OEL) report (the Edetate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.